donanemab

donanemab
Healthcare News, Research
Breakthrough trial shows donanemab slows alzheimer’s progression
Ritchelle Drilon Jul 18, 2023

Dementia Australia has welcomed the publication of the results of a trial showing that a new drug, donanemab, has been able to slow the progression

chat_bubble0 Comment visibility737 Views
donanemab
Research
Risky but effective: New Alzheimer’s drug donanemab shows promising results
Ritchelle Drilon May 9, 2023

Eli Lilly and Company’s new drug, donanemab, has shown promising results in slowing cognitive decline by 35% in people with early symptoms of Alzheimer’s disease.

chat_bubble0 Comment visibility886 Views

Healthcare Channel – Sharing knowledge and resources for Australia’s health and aged care sector

How can we help?

Request Media Kit

MENU LINKS

EVENTS

FOLLOW US

Facebook Linkedin Instagram

WRITE FOR US

We always welcome thought leaders ready to mentor the next generation. Be a Healthcare Channel learning partner today!

Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.

2024 All rights reserved. © Healthcare channel powered by Akolade.

Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.

2024 All rights reserved. © Healthcare channel powered by Akolade.